Showing results (601-610 of 2,992) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|January 1, 1997
Experience with antithrombin concentrates in neurotrauma patientsW K HootsSeminars in Thrombosis and Hemostasis|December 2, 1998
Resistance to activated protein C in women using oral contraceptivesM Spannagl, A Dick, A Assmann, et al.Seminars in Thrombosis and Hemostasis|December 2, 1998
Diagnosis of DIC in very low birth weight infantsA Shirahata, Y Shirakawa, C MurakamiSeminars in Thrombosis and Hemostasis|December 2, 1998
Anticoagulant activity in non-immunoglobulin fraction from plasma of patients with antiphospholipid syndromeM Sugimura, F Su, N Kanayama, et al.Seminars in Thrombosis and Hemostasis|January 1, 1993
Therapeutic use of low molecular weight heparins: the knowledge to date as applied to therapyR D Hull, G F PineoSeminars in Thrombosis and Hemostasis|January 1, 1993
First clinical experience with low molecular weight heparin LU 47311 (reviparin) for prevention of restenosis after percutaneous transluminal coronary angioplastyK M Schmid, M Preisack, W Voelker, et al.Seminars in Thrombosis and Hemostasis|January 1, 1993
Effects of unfractionated and low molecular weight heparin on platelet-induced thrombin formation time and platelet adhesionM Basic-Micic, H K BreddinSeminars in Thrombosis and Hemostasis|January 1, 1993
Treatment of factor VIII inhibitors: products and strategiesB G MacikSeminars in Thrombosis and Hemostasis|January 1, 1996
Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in ratsM Yamazaki, H Asakura, K Aoshima, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Platelet aggregation and coagulation inhibitors in leech saliva and their roles in leech therapyM Rigbi, M Orevi, A EldorPageof 300